GO:1901386 negative regulation of voltage-gated calcium channel activity: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901386 describes any biological process that stops, prevents, or reduces the frequency, rate, or extent of voltage-gated calcium channel activity.
• Voltage-gated calcium channels (VGCCs) are multi-subunit complexes that open in response to membrane depolarization and mediate Ca2+ influx essential for excitation-contraction coupling, secretion, and gene expression.
• Negative regulation of VGCC activity occurs through diverse mechanisms including direct G-protein binding, phosphorylation, accessory protein interactions, and calcium-dependent feedback.
• Key proteins involved include the channel pore-forming alpha1 subunits (CACNA1 genes), auxiliary beta/gamma subunits, G-protein beta-gamma dimers, and modulatory proteins such as BARP and SNAP-25.
• Dysregulation of VGCC negative regulation is linked to neurological disorders, cardiovascular disease, and pain syndromes, making it a target for therapeutic intervention.
• CRISPR-based knockout, point mutation, and knock-in models enable precise dissection of the molecular players that negatively regulate VGCC activity.
Description
Voltage-gated calcium channels (VGCCs) are transmembrane proteins that convert electrical signals into intracellular calcium signals, controlling processes as diverse as neurotransmitter release, muscle contraction, and hormone secretion. The activity of these channels must be tightly controlled; excessive or prolonged Ca2+ influx can be cytotoxic, while insufficient activity impairs normal physiology. The Gene Ontology term GO:1901386, negative regulation of voltage-gated calcium channel activity, captures the set of biological processes that reduce or prevent VGCC opening or conductance. Understanding this regulatory node is critical because it represents a convergence point for G-protein signaling, phosphorylation cascades, and accessory subunit interactions that fine-tune calcium entry. Researchers studying this term aim to identify the molecular brakes on VGCCs, how they are engaged under physiological and pathological conditions, and how they can be targeted therapeutically. This article synthesizes authoritative QuickGO annotation data and verified PubMed literature to provide a research-grade overview of GO:1901386, its mechanisms, key genes, disease relevance, and experimental strategies for investigation.
negative regulation of voltage-gated calcium channel activity At A Glance
| GO ID | GO:1901386 |
|---|---|
| GO term | negative regulation of voltage-gated calcium channel activity |
| Ontology | biological_process |
| Synonym | down regulation of voltage-gated calcium channel activity; inhibition of voltage-gated calcium channel activity; negative regulation of voltage-dependent calcium channel activity |
| Major function | Reduces or prevents calcium influx through voltage-gated calcium channels, thereby modulating excitation-contraction coupling, secretion, and gene expression. |
| Major regulators | G-protein beta-gamma dimers, protein kinases, accessory subunits (beta, gamma), and proteins such as BARP and SNAP-25. |
| Disease relevance | Implicated in hypertension, cardiac arrhythmias, chronic pain, and neurodegenerative disorders. |
| Research methods | Patch-clamp electrophysiology, calcium imaging, CRISPR knockout/knock-in, and biochemical assays. |
What Is GO:1901386?
GO:1901386 is defined by QuickGO as any process that stops, prevents, or reduces the frequency, rate, or extent of voltage-gated calcium channel activity. In other words, it encompasses all molecular and cellular events that negatively modulate the opening, conductance, or availability of calcium channels that are activated by changes in membrane voltage. This includes direct inhibition by G-protein beta-gamma subunits, phosphorylation of channel subunits, interaction with auxiliary proteins, and calcium-dependent feedback inhibition.
Why Is negative regulation of voltage-gated calcium channel activity Important in Cell Biology?
Negative regulation of VGCC activity is essential for maintaining calcium homeostasis and preventing excitotoxicity. It shapes the duration and amplitude of calcium signals that control neurotransmitter release, cardiac action potentials, and vascular tone. Dysregulation of this process contributes to diseases such as hypertension, epilepsy, and chronic pain, and it is a major mechanism by which G-protein-coupled receptors modulate neuronal excitability. Understanding GO:1901386 therefore provides insight into fundamental signaling logic and identifies potential drug targets for modulating calcium entry.
• Prevents calcium overload and excitotoxicity in neurons and cardiac myocytes.
• Mediates G-protein-coupled receptor inhibition of neurotransmitter release.
• Regulates vascular smooth muscle tone and blood pressure.
• Controls cardiac pacemaking and contractility.
• Modulates pain signaling in sensory neurons.
• Influences gene expression via calcium-dependent transcription pathways.
• Dysregulation is linked to hypertension, arrhythmias, and chronic pain.
• Provides targets for therapeutic modulation of calcium channels.
• Key to understanding synaptic plasticity and neuronal development.
• Relevant to endocrine secretion and hormone release.
What Happens During negative regulation of voltage-gated calcium channel activity?
Initiation by G-protein-coupled receptors
In simple terms: A receptor on the cell surface detects a signal and activates a G-protein, which then directly blocks calcium channels.
Many negative regulatory pathways begin with the activation of G-protein-coupled receptors (GPCRs). Upon ligand binding, the G-protein alpha subunit exchanges GDP for GTP, and the beta-gamma dimer dissociates to bind directly to the alpha1 subunit of VGCCs, stabilizing a closed state and reducing channel opening. This membrane-delimited pathway is a rapid and reversible mechanism for inhibiting calcium influx.
Phosphorylation-dependent modulation
In simple terms: Enzymes add phosphate groups to the channel or its partners, changing how the channel behaves.
Protein kinases such as protein kinase C (PKC) and tyrosine kinases can phosphorylate VGCC subunits or associated proteins, leading to reduced channel activity. For example, activity-dependent phosphorylation of SNAP-25 at Ser187 is required for SNAP-25-negative modulation of neuronal VGCCs. This phosphorylation creates a dynamic switch that tunes channel activity in response to cellular signals.
Accessory protein interactions
In simple terms: Helper proteins bind to the channel and put a brake on its activity.
Auxiliary subunits and interacting proteins can negatively regulate VGCCs. BARP (B-cell receptor-associated protein) suppresses VGCC activity and Ca2+-evoked exocytosis by interacting with the channel complex. Similarly, the beta subunit of VGCCs can modulate inactivation kinetics, and gamma subunits can reduce current amplitude. These protein-protein interactions provide additional layers of control.
Calcium-dependent feedback inhibition
In simple terms: Calcium itself can feed back to shut down the channels that let it in.
Elevated intracellular calcium can activate calcium-binding proteins like calmodulin, which then bind to VGCCs and promote inactivation. This negative feedback prevents excessive calcium entry and is critical for processes such as cardiac action potential repolarization and neuronal firing adaptation. In vascular smooth muscle, calcium-dependent ion channels contribute to myogenic tone regulation.
Long-term regulation via gene expression
In simple terms: Cells can change how many channels they make or how they are built over hours to days.
Sustained negative regulation can occur through changes in transcription or trafficking of VGCC subunits. For instance, chronic activation of certain signaling pathways reduces the surface expression of alpha1 subunits, leading to decreased calcium current. This long-term adaptation involves transcriptional regulators and is relevant to pathological conditions like hypertension.
Key Genes Involved in GO:1901386 negative regulation of voltage-gated calcium channel activity
The following genes encode proteins that directly or indirectly participate in the negative regulation of voltage-gated calcium channel activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CACNA1A | Pore-forming alpha1 subunit of P/Q-type VGCCs | Target of G-protein inhibition; mutations cause neurological disorders |
| CACNA1B | Pore-forming alpha1 subunit of N-type VGCCs | Key for neurotransmitter release; inhibited by G-proteins |
| CACNA1C | Pore-forming alpha1 subunit of L-type VGCCs | Cardiac and smooth muscle function; target of calcium blockers |
| CACNA1D | Pore-forming alpha1 subunit of L-type VGCCs | Endocrine and neuronal roles; mutations in autism |
| CACNA1E | Pore-forming alpha1 subunit of R-type VGCCs | Neuronal excitability; modulated by G-proteins |
| CACNA1G | Pore-forming alpha1 subunit of T-type VGCCs | Pacemaking activity; involved in pain |
| CACNB1 | Beta auxiliary subunit | Modulates channel gating and inactivation |
| CACNB2 | Beta auxiliary subunit | Regulates trafficking and gating; linked to Brugada syndrome |
| CACNG1 | Gamma auxiliary subunit | Modulates channel properties in muscle |
| GNB1 | G-protein beta subunit | Forms beta-gamma dimer that inhibits VGCCs |
| GNG2 | G-protein gamma subunit | Part of beta-gamma dimer for VGCC inhibition |
| BARP | Suppressor of VGCC activity | Inhibits Ca2+-evoked exocytosis |
| SNAP25 | SNARE protein | Phosphorylation-dependent negative modulation of VGCCs |
| KCNQ4 | Potassium channel | Indirectly affects calcium channel activity via membrane potential |
| BK channels (KCNMA1) | Calcium-activated potassium channels | Feedback regulation of calcium entry in smooth muscle |
| CACNA1H | T-type calcium channel | Involved in pain and epilepsy |
| CACNA1F | L-type calcium channel | Retinal function; mutations cause blindness |
How Is negative regulation of voltage-gated calcium channel activity Regulated?
The negative regulation of VGCC activity is itself regulated at multiple levels. GPCR signaling pathways provide rapid, reversible inhibition through G-protein beta-gamma dimers. Phosphorylation by kinases such as PKC and Src family kinases can either enhance or relieve inhibition depending on the channel subtype and cellular context. Calcium-dependent feedback via calmodulin and calcium-binding proteins acts as a built-in brake. Additionally, accessory proteins like BARP can be transcriptionally regulated, altering the set point for channel inhibition. In vascular smooth muscle, BK channels activated by calcium and voltage provide a negative feedback loop that limits calcium entry and controls myogenic tone.
negative regulation of voltage-gated calcium channel activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CACNA1A | Epilepsy, migraine, ataxia | Knockout mouse, point mutation knock-in |
| CACNA1C | Brugada syndrome, Timothy syndrome | Cardiomyocyte knockout, overexpression |
| CACNA1D | Autism, primary aldosteronism | Neuronal knockout, point mutation |
| CACNA1B | Chronic pain | Sensory neuron knockout, knockdown |
| KCNMA1 | Hypertension, epilepsy | Smooth muscle knockout, overexpression |
Neurological and psychiatric disorders
Dysregulation of VGCC negative regulation is implicated in epilepsy, migraine, and autism spectrum disorders. Mutations in CACNA1A, which encodes the P/Q-type channel, can impair G-protein-mediated inhibition and lead to neuronal hyperexcitability. Similarly, CACNA1D mutations affecting L-type channel inactivation have been linked to autism and endocrine disorders. The balance between channel opening and negative regulation is critical for normal brain function.
Cardiovascular disease
In the heart and vasculature, negative regulation of L-type and T-type calcium channels influences contractility, heart rate, and blood pressure. Impaired inhibition can contribute to hypertension and arrhythmias. BK channels in vascular smooth muscle provide a negative feedback mechanism; their dysfunction is associated with altered myogenic tone and hypertension.
Chronic pain
N-type calcium channels (CACNA1B) in sensory neurons are subject to G-protein-mediated inhibition. Loss of this negative regulation can enhance pain signaling, making it a target for analgesics. Understanding the molecular players in this pathway is essential for developing new pain therapies.
From negative regulation of voltage-gated calcium channel activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate VGCC activity? | CRISPR knockout in neuronal or cardiac cell line |
| Does a specific point mutation alter channel inhibition? | CRISPR point mutation knock-in |
| How does a regulatory protein interact with the channel? | Tagged knock-in for co-immunoprecipitation |
| What is the effect of overexpression of a negative regulator? | CRISPR overexpression (CRISPRa) or lentiviral overexpression |
| Which genes are essential for G-protein-mediated inhibition? | Genome-wide CRISPR library screening |
| How does calcium feedback control channel activity? | Calcium imaging in knockout cells |
How to Study the negative regulation of voltage-gated calcium channel activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Ion channel currents and gating | Direct measurement of VGCC inhibition |
| Calcium imaging | Intracellular Ca2+ concentration | Live-cell monitoring of channel activity |
| Co-immunoprecipitation | Protein-protein interactions | Identifying channel-regulator complexes |
| Western blotting | Protein expression and phosphorylation | Assessing phosphorylation-dependent regulation |
| CRISPR knockout screening | Gene function on a global scale | Discovering novel negative regulators |
| RNA-seq | Transcriptional changes | Long-term regulation of channel expression |
| Proteomics | Protein abundance and modifications | Global analysis of signaling pathways |
Electrophysiology
Patch-clamp recordings are the gold standard for measuring VGCC activity and its negative regulation. Whole-cell and single-channel recordings can quantify current amplitude, inactivation kinetics, and the effects of G-protein activation or phosphorylation. These methods provide direct functional readouts of channel inhibition.
Calcium imaging
Fluorescent calcium indicators such as Fura-2 or GCaMP allow real-time monitoring of intracellular calcium changes in live cells. This approach can assess how negative regulators affect calcium influx through VGCCs in response to depolarization.
Biochemical and proteomic assays
Co-immunoprecipitation, pull-down assays, and mass spectrometry can identify protein-protein interactions between VGCC subunits and negative regulators. Phosphorylation status can be analyzed by Western blotting with phospho-specific antibodies.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can systematically identify genes that negatively regulate VGCC activity. Cells are engineered to express a calcium-sensitive reporter, and channel activity is monitored after depolarization to uncover modifiers.
How CRISPR Can Be Used to Study GO:1901386 negative regulation of voltage-gated calcium channel activity
Knockout
CRISPR knockout of candidate genes such as CACNA1B or GNB1 can abolish specific negative regulatory pathways, leading to increased VGCC activity. This approach is used to test whether a gene is necessary for channel inhibition.
Point Mutation
Introducing precise point mutations (e.g., in phosphorylation sites of SNAP-25 or in the G-protein binding site of CACNA1A) allows researchers to dissect the contribution of individual residues to negative regulation without altering protein expression levels.
Knock-in
Knock-in of tagged versions of channel subunits or regulatory proteins (e.g., HA-tagged CACNA1A) enables biochemical purification and interaction studies in a physiological context.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of negative regulators like BARP can enhance channel inhibition, providing gain-of-function models to study the consequences of reduced calcium influx.
How EDITGENE Supports negative regulation of voltage-gated calcium channel activity Research
Researchers studying negative regulation of voltage-gated calcium channel activity-related genes often need to determine whether a candidate gene is causally involved in modulating channel function. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of genes implicated in GO:1901386.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of voltage-gated calcium channel activity research.
Frequently Asked Questions About negative regulation of voltage-gated calcium channel activity
What is GO:1901386?
GO:1901386 is a Gene Ontology term for any biological process that stops, prevents, or reduces the frequency, rate, or extent of voltage-gated calcium channel activity.
What genes are involved in negative regulation of voltage-gated calcium channel activity?
Key genes include CACNA1A, CACNA1B, CACNA1C, GNB1, GNG2, BARP, and SNAP25, among others.
How is voltage-gated calcium channel activity negatively regulated?
It is regulated by G-protein beta-gamma dimers, phosphorylation, accessory protein interactions, and calcium-dependent feedback.
What diseases are associated with dysregulation of this process?
Dysregulation is linked to epilepsy, migraine, autism, hypertension, cardiac arrhythmias, and chronic pain.
What experimental methods are used to study GO:1901386?
Patch-clamp electrophysiology, calcium imaging, co-immunoprecipitation, and CRISPR screens are commonly used.
Can CRISPR be used to study negative regulation of VGCCs?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect the molecular players.
What is the role of G-proteins in VGCC inhibition?
G-protein beta-gamma dimers bind directly to VGCC alpha1 subunits and stabilize a closed state, reducing calcium influx.
How does phosphorylation affect VGCC activity?
Phosphorylation of channel subunits or associated proteins like SNAP-25 can inhibit channel activity.
What is BARP and how does it regulate calcium channels?
BARP is a protein that suppresses VGCC activity and Ca2+-evoked exocytosis by interacting with the channel complex.
Why is negative regulation of VGCCs important for health?
It prevents calcium overload, maintains normal neuronal and cardiac function, and controls vascular tone.
Conclusion
GO:1901386, negative regulation of voltage-gated calcium channel activity, is a critical biological process that fine-tunes calcium entry into cells. It involves a sophisticated interplay of G-proteins, kinases, accessory proteins, and calcium feedback mechanisms. Dysregulation of this process underlies numerous diseases, making it a prime target for therapeutic intervention. Advances in CRISPR-based genome editing now allow researchers to precisely dissect the genes and pathways involved, accelerating the development of new treatments for neurological and cardiovascular disorders.
References
- 1. Catterall WA. 2000. Structure and regulation of voltage-gated Ca2+ channels.. Annu Rev Cell Dev Biol 16:521-55 PMID: 11031246
- 2. Dolphin AC. 2003. G protein modulation of voltage-gated calcium channels.. Pharmacol Rev 55(4):607-27 PMID: 14657419
- 3. Béguin P et al.. 2014. BARP suppresses voltage-gated calcium channel activity and Ca2+-evoked exocytosis.. J Cell Biol 205(2):233-49 PMID: 24751537
- 4. Gao Y et al.. 2023. Molecular insights into the gating mechanisms of voltage-gated calcium channel Ca(V)2.3.. Nat Commun 14(1):516 PMID: 36720859
- 5. Dopico AM et al.. 2018. Calcium- and voltage-gated BK channels in vascular smooth muscle.. Pflugers Arch 470(9):1271-1289 PMID: 29748711
- 6. Pozzi D et al.. 2008. Activity-dependent phosphorylation of Ser187 is required for SNAP-25-negative modulation of neuronal voltage-gated calcium channels.. Proc Natl Acad Sci U S A 105(1):323-8 PMID: 18162553
- 7. Chambard JM et al.. 2005. Regulation of the voltage-gated potassium channel KCNQ4 in the auditory pathway.. Pflugers Arch 450(1):34-44 PMID: 15660259
- 8. Jackson WF. 2021. Calcium-Dependent Ion Channels and the Regulation of Arteriolar Myogenic Tone.. Front Physiol 12:770450 PMID: 34819877
